Harpoon Therapeutics Inc. (HARP)
NASDAQ: HARP
· Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM
Harpoon Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.8M | 1.06M | -11.34M | -18.42M | -11.64M | -17.35M | -20.32M | -21.55M | -16.68M | -16.76M | -61.72M |
Depreciation & Amortization | 236K | 370K | 662K | 678K | 527K | 548K | 604K | 558K | 534K | 549K | 549K |
Stock-Based Compensation | 918K | 1.06M | 1.13M | 1.49M | 1.78M | 2.52M | 2.84M | 2.65M | 2.34M | 2.34M | 2.14M |
Other Working Capital | -7.05M | -22.35M | -9.5M | -4.46M | -14.59M | -6.81M | -9.78M | 274K | -7.25M | -52.77M | 39.29M |
Other Non-Cash Items | -9.02M | 3.09M | 464K | 213K | 146K | 310K | 465K | 152K | 144K | 135K | 25K |
Deferred Income Tax | -180K | 2.25M | n/a | n/a | n/a | n/a | n/a | 515K | 686K | 594K | 574K |
Change in Working Capital | -6.69M | -23.02M | -10.21M | -2.35M | -14.76M | -7.63M | -8.83M | 845K | -7.7M | -53.42M | 40.36M |
Operating Cash Flow | -16.53M | -15.18M | -19.29M | -18.39M | -23.95M | -21.6M | -25.24M | -16.83M | -20.68M | -66.57M | -18.08M |
Capital Expenditures | -91K | n/a | n/a | -28K | -266K | -53K | 597K | -55K | n/a | n/a | -45K |
Cash Acquisitions | n/a | 341K | 938K | n/a | n/a | n/a | -597K | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.94M | -12.71M | n/a | -11.51M | -12.92M | -1M | -10.51M | -17.4M | -34.1M | -17.51M | -82.96M |
Sales Maturities Of Investments | 2M | n/a | 1.5M | 14.28M | 18.83M | 41.03M | 40.37M | 36.14M | 19.98M | 87.2M | 43.1M |
Other Investing Acitivies | n/a | n/a | n/a | 11.51M | n/a | -597K | 597K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.03M | -12.37M | 2.44M | 14.25M | 5.65M | 39.38M | 30.46M | 18.69M | -14.12M | 69.69M | -39.9M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 748.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.03M | -1.04M | 26.62M | 5.39M | 101K | 52K | 830K | 47K | 380K | 2.95M | 108.14M |
Financial Cash Flow | 2.03M | -1.04M | 26.62M | 5.39M | 101K | 52K | 830K | 47K | 380K | 2.95M | 108.14M |
Net Cash Flow | -15.53M | -28.59M | 9.77M | 1.25M | -18.2M | 17.83M | 6.05M | 1.9M | -34.42M | 6.08M | 50.16M |
Free Cash Flow | -16.62M | -15.18M | -19.29M | -18.42M | -24.22M | -21.66M | -24.64M | -16.89M | -20.68M | -66.57M | -18.12M |